Some 800 papers will be retracted from Russian academic journals after a “bombshell” investigation.  A Russian Academy of Sciences commission found more than 2,500 papers that were plagiarized, self-plagiarized, or had “gift authorship” with researchers listed as co-authors…

Sickle cell patients have been caught in the crossfire as ERs shift their pain protocol, trying to provide effective pain relief without spurring addiction.   "We start creating people with addiction problems at a very early age in sickle cell disease," observes Troy…

Federally funded researchers have disclosed some $188 million in “significant” financial conflicts of interest since 2012, after the NIH toughened up reporting rules.   That’s a low estimate, since 44% of the disclosures did not list a dollar value. The reporting range tops…

Nicole Stringer takes 100 daily pills a day to treat cystic fibrosis—and that’s just part of her routine. She also suffers from an antibiotic-resistant superbug.   Her best hope: natural killers drawn from municipal sewage.   Found wherever there’s bacteria, phages are “…

They live in the country that spends by far the most on health care—yet for the past decade more young Americans have been dying in the prime of their lives. A “strikingly bleak” JAMA report counted 33,000 “excess deaths” since 2010, and the trend spans gender, racial and…

Ethiopia experiences 7X the global prevalence of neural tube defects, which can mean babies born without brains or with protruding spinal cords.     “Probably every other day we see a child that is so bad we can’t help them,” says Tony Magana of Mekelle University School of…

This wasn't your average classroom experiment.  Children at a North London school were asked to bring in samples of family soup recipes from around the world—Imperial College London researchers tested them for malaria-fighting powers. Some of these home broth remedies were…

Canada and Europe have stirred debate by opting to release clinical study reports underlying medical products approved or rejected by regulators. The US has no such practice, treating this information as commercially sensitive. But some experts want American regulators to…

The notorious CRISPR twins scandal in China sparked fresh crackdowns on gene editing technology in the US and China, but Russia remains a “legislative vacuum” on the issue, with Putin himself likely giving any go-ahead for research.   CRISPR technology has never been…